XML 116 R98.htm IDEA: XBRL DOCUMENT v3.24.1
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
 7 Months Ended 12 Months Ended
Feb. 06, 2023
Jan. 10, 2023
Dec. 28, 2022
Oct. 13, 2022
Jan. 07, 2022
Dec. 06, 2021
Sep. 02, 2021
Jun. 30, 2022
Dec. 31, 2023
Dec. 31, 2022
Jun. 02, 2023
Class of Stock [Line Items]                      
Shares, cancelled                 3,625    
Purchase fixed price per shares                 $ 22.00    
Sale of stock price per share       $ 10.00              
Number of shares issued, value       $ 15,000,000     $ 9,403,600        
Conversion price per share                 $ 20.00    
Preferred stock, redemption terms       The holders of the Series A Preferred Stock and Series B Preferred Stock have the right to require the Company to redeem their shares of the relevant series at a price per share equal to 105% of the stated value of such shares commencing (i) after the earlier of (1) the receipt of stockholder approval of the Amendments and (2) sixty (60) days after the closing of the 2022 Offering and (ii) before the date that is ninety (90) days after such closing. The Company has the option to redeem the Series A Preferred Stock and Series B Preferred Stock at a price per share equal to 105% of the stated value of such shares commencing after the 90th day following the closing of the 2022 Offering, subject to the holders’ rights to convert the shares prior to such redemption              
Stock redeemed or called during period, value                   $ 15,750,000  
Carrying amount of redeemed                   13,365,000  
Loss on redemption                   2,385,000  
Number of shares issued     25,000                
Reverse stock split 1-for-20 reverse stock split                    
Reverse stock split related shares                 24,206    
Net income (loss) attributable to noncontrolling interest                 $ 224,598 407,933  
Face value                 147,781 150,000 $ 125,000
Conversion of convertible securities                 $ 119,750    
Cancellation of common stock                 3,625    
Convertible Debt [Member]                      
Class of Stock [Line Items]                      
Number of new shares issued                 25,000    
Purchase fixed price per shares                 $ 5.00    
Face value                 $ 125,000    
Conversion of convertible securities                 $ 119,750    
Nobility Healthcare LLC [Member]                      
Class of Stock [Line Items]                      
Subsidiary, ownership percentage, parent                 49.00%    
Net income (loss) attributable to noncontrolling interest                 $ 224,598 $ 407,933  
Nobility Healthcare LLC [Member]                      
Class of Stock [Line Items]                      
Equity method investment, ownership percentage                 51.00%    
Stock Repurchase Program [Member]                      
Class of Stock [Line Items]                      
Number of repurchased shares               273,042   186,299  
Number of repurchase               $ 6,001,602      
IPO [Member]                      
Class of Stock [Line Items]                      
Redemption price percentage       105.00%              
Series A Convertible Redeemable Preferred Stock [Member]                      
Class of Stock [Line Items]                      
Number of new shares issued       1,400,000              
Preferred stock, par or stated value per share       $ 0.001              
Series B Convertible Redeemable Preferred Stock [Member]                      
Class of Stock [Line Items]                      
Number of new shares issued       100,000              
Preferred stock, par or stated value per share       $ 0.001              
Purchase fixed price per shares       $ 9.50              
Original issue discount percentage       5.00%              
Series B Preferred Stock [Member]                      
Class of Stock [Line Items]                      
Preferred stock, voting rights                 The Certificate of Designation for the Series B Preferred Stock provides, in particular, that the Series B Preferred Stock will have no voting rights other than the right to vote on the Amendments and each share of Series B Preferred Stock entitles the holder thereof the right to cast 2,500 votes on the Amendments    
Stock redeemed or called during period, shares                   100,000  
Series A Preferred Stock [Member]                      
Class of Stock [Line Items]                      
Stock redeemed or called during period, shares                   1,400,000  
Minimum [Member] | Stock Repurchase Program [Member]                      
Class of Stock [Line Items]                      
Number of repurchase                   $ 4,026,523  
Maximum [Member] | Stock Repurchase Program [Member]                      
Class of Stock [Line Items]                      
Proceeds from common stock           $ 10,000,000.0          
Officers [Member]                      
Class of Stock [Line Items]                      
Common stock issuance granted   22,500     26,250            
Vesting drescription   Such shares will generally vest over a period of one to five years on their respective anniversary dates in January through January 2028, provided that each grantee remains an officer or employee on such dates.     Such shares will vest over various periods ranging from one to five years on the anniversary of the grant date, provided that each grantee remains an officer or employee on such dates.            
Employees [Member]                      
Class of Stock [Line Items]                      
Common stock issuance granted         9,500            
Employees [Member] | Minimum [Member]                      
Class of Stock [Line Items]                      
Vesting period         2 years            
Employees [Member] | Maximum [Member]                      
Class of Stock [Line Items]                      
Vesting period         5 years            
Financial Advisor [Member] | Series A Convertible Redeemable Preferred Stock [Member]                      
Class of Stock [Line Items]                      
Reimbursement description       In connection with the 2022 Offering, the Company paid A.G.P./Alliance Global Partners (the “Financial Advisor”) an aggregate cash fee equal to $750,000 and reimbursed the Financial Advisor for certain of its expenses in an amount not to exceed $135,000              
Aggregate cash fee       $ 750,000              
New Employees [Member]                      
Class of Stock [Line Items]                      
Common stock issuance granted   12,500                  
New Employees [Member] | Minimum [Member]                      
Class of Stock [Line Items]                      
Vesting period   1 year                  
New Employees [Member] | Maximum [Member]                      
Class of Stock [Line Items]                      
Vesting period   2 years